We Are Honored to be Named As One of TIME Magazine's 50 Genius Companies For Our Work in Advancing Cannabinoid Science

Our Story

We've achieved this distinction through innovation and persistence.

 

Medical Information

Access scientific and clinical information on Greenwich Biosciences products.

READ MORE

Spotlight News

Spotlight News
Apr 25, 2018
Greenwich Clinical Program Reflects Dedication to Scientific Rigor, Unmet Patient Needs
READ MORE >

Press Releases

Nov 27, 2018
Company Announces Results from Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) Oral Solution CV in Patients with Dravet Syndrome
Read More >

Patients & Caregivers

“Our primary purpose is to make a positive and meaningful difference in the lives of patients and their caregivers.”

–Justin Gover,
Chief Executive Officer 

 

Careers

Become part of a dynamic, cutting-edge pharmaceutical company on the forefront of a new category of therapeutic treatment.